2024
|
Invention
|
Modified polypeptide of activated blood coagulation factor v, and method for measuring activity o... |
|
Invention
|
Method for producing three-dimensional cell structure. The purpose of the present invention is to... |
|
Invention
|
Method for inspecting coronary vasospasm, peripheral artery disease, or multi vessel disease. One... |
|
Invention
|
Manufacturing method of cellular structures.
The present disclosure aims to provide a manufactur... |
|
Invention
|
Assisting clinical decision-making in drug therapy for acute heart failure patients. Embodiments ... |
|
Invention
|
Monitoring cardiac contractility during cardiac treatments. A computer-implemented method may be ... |
|
Invention
|
Device for determining type of arrhythmia, method for determining type of arrhythmia, and program... |
|
Invention
|
Premature contraction determination device, premature contraction determination method, and prema... |
|
Invention
|
Receiver and power transmission system. An implant device comprises a first resonance circuit (13... |
|
Invention
|
Takayasu arteritis examination method. One purpose of the present disclosure is to provide a meth... |
2023
|
Invention
|
Agent for prevention and/or treatment of cognitive impairment.
This invention provides a novel p... |
|
Invention
|
Stroke test method and stroke ameliorating agent. One purpose of the present disclosure is to pro... |
|
Invention
|
Prophylactic agent and/or therapeutic agent for heart diseases and laminopathy. The present inven... |
|
Invention
|
Blood pressure measurement device. Provided is a blood pressure measurement device that makes it ... |
|
Invention
|
Blood pressure measurement device. Provided is a blood pressure measurement device that can accur... |
2022
|
Invention
|
Method for testing pulmonary hypertension, pathological animal model for pulmonary arterial hyper... |
|
Invention
|
Determination method using genetic polymorphism. The present invention provides a method for pred... |
|
Invention
|
Amelioration and treatment of brain disorder resulting from fetal growth retardation using plurip... |
|
Invention
|
Methods, assays and compositions for measuring brain damage or harm during surgery.
The present ... |
|
Invention
|
Methods, assays and compositions for measuring brain damage or harm during surgery. The present d... |
|
Invention
|
Antisense nucleic acid targeting pcsk9.
Provided is an oligonucleotide conjugate comprising an o... |
|
Invention
|
Prophylactic or therapeutic agent for severe pulmonary hypertension, refractory pulmonary hyperte... |
2021
|
Invention
|
Blood pressure monitoring apparatus.
A blood pressure monitoring apparatus including a linear re... |
|
Invention
|
Blood pressure monitoring device. RR, actual compression pressures PcH1 and PcH2 in a low pressur... |
|
Invention
|
Method for detecting genetic polymorphism.
The present invention chiefly aims to provide a new m... |
|
Invention
|
Method for detecting genetic polymorphism. The present invention mainly addresses the problem of ... |
|
Invention
|
Manufacturing method of a cell structure. The present disclosure aims to provide a manufacturing ... |
|
Invention
|
Cell structure, cell culture, and manufacturing method of a cell structure.
The present disclosu... |
|
Invention
|
Anti-human trpv2 antibody. The present invention provides an anti-human TRPV2 antibody, which rec... |
|
Invention
|
Therapeutic agent for mild cognitive impairment.
The present disclosure provides a method of pre... |
|
Invention
|
Therapeutic agent for mild cognitive impairment. The present invention mainly addresses the probl... |
|
Invention
|
Antisense nucleic acid targeting apoc3.
The present invention provides an antisense oligomer hav... |
|
Invention
|
Antisense nucleic acid targeting apoc3. The present invention provides: an antisense oligomer hav... |
|
Invention
|
Mask. This mask, to which a cartridge with a filter can be attached, is provided with: a main bod... |
|
Invention
|
Marker for pulmonary hypertension. The purpose of the present invention is to identify a marker g... |
2020
|
Invention
|
Drug for preventing and/or treating dementia. Provided is a drug superior for preventing and/or t... |
|
Invention
|
Agent for repairing or suppressing dna damage. The present invention addresses the problem of rep... |
|
Invention
|
Drug for treating symptom of cerebral infarction in acute stage cerebral infarction patient. The ... |
|
Invention
|
Therapeutic agent for peripartum cardiomyopathy.
According to the present invention, a pharmaceu... |
|
Invention
|
Therapeutic agent for peripartum cardiomyopathy. The present invention provides a pharmaceutical ... |
|
Invention
|
Cerebral infarction treatment support system. A cerebral infarction treatment support system (100... |
|
Invention
|
System for assisting with treatment of stroke. This system (100) for assisting with treatment of ... |
|
Invention
|
Klf induced cardiomyogenesis.
The technology relates to a method for inducing cardiomyogenesis c... |
|
Invention
|
Klf induced cardiomyogenesis. The technology relates to a method for inducing cardiomyogenesis co... |
|
Invention
|
Hepatic fibrosis-inhibiting agent and brown fat cell-activating agent containing taxifolin.
The ... |
|
Invention
|
Macrophage imaging agent.
Composite particles, each of which is obtained by forming, on the surf... |
2019
|
Invention
|
Antitumor effect potentiator. An activator suitable for immune response in tumor immunotherapy us... |
|
Invention
|
Arteriosclerosis and arteriosclerosis-related disease marker.
The present invention is intended ... |
|
Invention
|
Novel aortic aneurysm marker.
The present invention is intended to provide a novel biomarker cap... |
|
P/S
|
Electronic publications, downloadable. Printed matter. Processed meat products; processed seafood... |
2018
|
Invention
|
Antisense nucleic acid targeting pcsk9. Provided is an oligonucleotide conjugate comprising an ol... |